Transparency Notifications from Shareholders : comparemela.c

PRESS RELEASEREGULATED INFORMATION3 April 2024, 06:00 pm CEST Ghent, Belgium – 3 April 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, announces today that it received transparency notifications from the shareholders listed below, notifying the number of voting rights attached to shares mentioned next to their respective names in the table below. The transparency no

Related Keywords

Canada , United States , Vlaams Gewest , Region Flamande , Belgium , Belgian , American , Adrianus Van Herk , Company Premarket Approval , Company Or Sequanamedical , Belgian Financial Services , Sequana Medical , Euronext Brussels , Participatiemaatschappij Vlaanderen , Het Vlaams Gewest , Belgian Act , Belgian Transparency Act , Markets Authority , Premarket Approval , North American , Data Safety Monitoring Board , The Company , Voting Rights , Sequana , Heart Failure , Articipatiemaatschappij Vlaanderen Nv , Notification , Company ,